RAPT Therapeutics Inc’s Market Journey: Closing Weak at 3.82, Down -0.52

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The closing price of RAPT Therapeutics Inc (NASDAQ: RAPT) was $3.82 for the day, down -0.52% from the previous closing price of $3.84. In other words, the price has decreased by -$0.52 from its previous closing price. On the day, 0.77 million shares were traded. RAPT stock price reached its highest trading level at $3.9895 during the session, while it also had its lowest trading level at $3.745.


Our analysis of RAPT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.01 and its Current Ratio is at 7.01. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.

Barclays Downgraded its Overweight to Equal Weight on May 10, 2024, whereas the target price for the stock was revised from $13 to $4.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 05 ’24 when Brockstedt Dirk G. sold 898 shares for $22.78 per share. The transaction valued at 20,456 led to the insider holds 27,820 shares of the business.

HO WILLIAM sold 2,500 shares of RAPT for $54,200 on Dec 21 ’23. The Chief Medical Officer now owns 15,020 shares after completing the transaction at $21.68 per share. On Nov 28 ’23, another insider, HO WILLIAM, who serves as the Chief Medical Officer of the company, sold 1,500 shares for $13.72 each. As a result, the insider received 20,580 and left with 17,520 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPT now has a Market Capitalization of 133331368 and an Enterprise Value of -1924721.

Stock Price History:

Over the past 52 weeks, RAPT has reached a high of $27.35, while it has fallen to a 52-week low of $3.82. The 50-Day Moving Average of the stock is -41.56%, while the 200-Day Moving Average is calculated to be -73.26%.

Shares Statistics:

RAPT traded an average of 886.67K shares per day over the past three months and 605700 shares per day over the past ten days. A total of 34.40M shares are outstanding, with a floating share count of 30.58M. Insiders hold about 12.39% of the company’s shares, while institutions hold 81.61% stake in the company. Shares short for RAPT as of 1715731200 were 3112663 with a Short Ratio of 3.51, compared to 1713139200 on 3184129. Therefore, it implies a Short% of Shares Outstanding of 3112663 and a Short% of Float of 11.9799994.

Most Popular